# Pioglitazone Hydrochloride and Metformin Hydrochloride

NDC: 65862-525
Generic name: Pioglitazone Hydrochloride and Metformin Hydrochloride
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130213

FDA application: ANDA200823

## Active ingredients

- METFORMIN HYDROCHLORIDE: 500 mg/1
- PIOGLITAZONE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-525"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-525
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1fa2703e-fb73-44d5-aaa2-b12b1090d42c